Clinical Oncology - Issue 5/2017
Review
B. Bolerázska, E. Ďurovcová, M. Mareková
T. Kazda, R. Lakomý, A. Poprach, P. Pospíšil, R. Jančálek, P. Šlampa
R. Lakomý, T. Kazda, A. Poprach, P. Pospíšil, R. Jančálek, P. Šlampa
Original Articles
T. Büchler, B. Melichar, D. Vrána, R. Lemstrová, J. Fínek, L. Dušek, K. Petrakova, J. Prausová
M. Houdova Megova, J. Drábek, Z. Dwight, R. Trojanec, V. Koudelakova, J. Vrbková, O. Kalita, S. Mlcochova, M. Rabcanova, M. Hajdúch
S. Kolivand, E. Motevaseli, M. Cheki, A. Mahmoudzadeh, A. Shirazi, V. Fait
Case Report
A. Špótová, K. Husáková, A. Hrašková, M. Mikesková, J. Puškáčová, S. Hederová, M. Jamárik, E. Rabenseifertová, Z. Jalovecká, A. Kolenova, Z. Šubová
Clinical Oncology
2017 Issue 5
Most read in this issue
- Controversy in the Postoperative Treatment of Low-grade Gliomas
- The Role of Chemotherapy in the Treatment of Low-grade Gliomas
- Treatment Refusal in Pediatric Oncology
- Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas – a Retrospective, Single-centre Molecular Genetics Study of Gliomas